Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saif Zaman

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Journal of Pancreatology|March 25, 2024
Acute pancreatitis: pathogenesis and emerging therapiesSaif Zaman, Fred Gorelick
Cell Cycle (Georgetown, Tex.)|November 6, 2018
MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastomaSaif Zaman, Boris I Chobrutskiy, George Blanck
Cancer Cell International|April 10, 2019
An age-based, RNA expression paradigm for survival biomarker identification for pediatric neuroblastoma and acute lymphoblastic leukemiaAndrea Diviney, Boris I Chobrutskiy, Saif Zaman, et al.
Oncology Reports|December 12, 2018
MAPT (Tau) expression is a biomarker for an increased rate of survival for low‑grade gliomaSaif Zaman, Boris I Chobrutskiy, Dhiraj Sikaria, et al.
Journal of Gastrointestinal Cancer|April 27, 2023
Specific Intratumor Bacteria Genera and TRG Recombinations Associated with Greater Survival Probability in Alimentary Tract CancersSaif Zaman, Boris I Chobrutskiy, Jessica U Quach, et al.
Oncotargets and Therapy|March 19, 2019
Targeting Trop-2 in solid tumors: future prospectsSaif Zaman, Hassan Jadid, Aaron C Denson, et al.
BMJ Open Gastroenterology|February 23, 2023
Appendiceal adenocarcinoma is associated with better prognosis than cecal adenocarcinoma: a population-based comparative survival studyGeorge Chen, Kay Chen, Laura Sahyoun, et al.
Cancer Treatment and Research Communications|August 10, 2020
Immunogenomics of colorectal adenocarcinoma: Survival distinctions represented by immune receptor, CDR3 chemical features and high expression of BTN gene family membersMichael J Diaz, Boris I Chobrutskiy, Saif Zaman, et al.
Breast Cancer Research and Treatment|November 12, 2020
Chemical features of blood-borne TRG CDR3s associated with an increased overall survival in breast cancerAndrea Chobrutskiy, Boris I Chobrutskiy, Saif Zaman, et al.
Journal of Molecular Neuroscience : MN|March 5, 2021
Systemic Adaptive Immune Parameters Associated with Neuroblastoma Outcomes: the Significance of Gamma-Delta T CellsEtienne C Gozlan, Boris I Chobrutskiy, Saif Zaman, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Journal of Pancreatology|March 25, 2024
Acute pancreatitis: pathogenesis and emerging therapiesSaif Zaman, Fred Gorelick
Cell Cycle (Georgetown, Tex.)|November 6, 2018
MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastomaSaif Zaman, Boris I Chobrutskiy, George Blanck
Cancer Cell International|April 10, 2019
An age-based, RNA expression paradigm for survival biomarker identification for pediatric neuroblastoma and acute lymphoblastic leukemiaAndrea Diviney, Boris I Chobrutskiy, Saif Zaman, et al.
Oncology Reports|December 12, 2018
MAPT (Tau) expression is a biomarker for an increased rate of survival for low‑grade gliomaSaif Zaman, Boris I Chobrutskiy, Dhiraj Sikaria, et al.
Journal of Gastrointestinal Cancer|April 27, 2023
Specific Intratumor Bacteria Genera and TRG Recombinations Associated with Greater Survival Probability in Alimentary Tract CancersSaif Zaman, Boris I Chobrutskiy, Jessica U Quach, et al.
Oncotargets and Therapy|March 19, 2019
Targeting Trop-2 in solid tumors: future prospectsSaif Zaman, Hassan Jadid, Aaron C Denson, et al.
BMJ Open Gastroenterology|February 23, 2023
Appendiceal adenocarcinoma is associated with better prognosis than cecal adenocarcinoma: a population-based comparative survival studyGeorge Chen, Kay Chen, Laura Sahyoun, et al.
Cancer Treatment and Research Communications|August 10, 2020
Immunogenomics of colorectal adenocarcinoma: Survival distinctions represented by immune receptor, CDR3 chemical features and high expression of BTN gene family membersMichael J Diaz, Boris I Chobrutskiy, Saif Zaman, et al.
Breast Cancer Research and Treatment|November 12, 2020
Chemical features of blood-borne TRG CDR3s associated with an increased overall survival in breast cancerAndrea Chobrutskiy, Boris I Chobrutskiy, Saif Zaman, et al.
Journal of Molecular Neuroscience : MN|March 5, 2021
Systemic Adaptive Immune Parameters Associated with Neuroblastoma Outcomes: the Significance of Gamma-Delta T CellsEtienne C Gozlan, Boris I Chobrutskiy, Saif Zaman, et al.
Pageof 6